MAP1LC3B and neoplasm: Kaplan-Meier survival analysis was conducted to assess overall survival (OS) in months based on MMR status, LC3β status, tumor stage and nodal stage, with differences evaluated using the log-rank test (Table 3, Figures 2A–D).